Bioinks and 3D printed organs the focus of new CollPlant division

Written by Freya Leask

CollPlant, developer of plant-based rhCollagen technology for tissue repair, will be expanding its research into bioprinting organs and other tissues. Research into collagen-based bioinks will be the focus of a new division established by CollPlant (Israel). The inks are intended to be utilized in the production of 3D printed organs and other tissues. Yehiel Tal, CEO, CollPlant, noted, “Over the last several months, we have substantially ramped up our activities in the 3D printing field leveraging biological ink that we are developing based on our rhCollagen technology. The collagen protein is a key building block in connective tissues in the...

To view the full article, please register now for access

It's completely free